Introduction : Starting in late 2019, a novel coronavirus rapidly spread throughout the world, resulting in a global pandemic. aim of the work: The virus was designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the illness it caused coronavirus disease 2019 (COVID-19). Patients and methods :The clinical spectrum of COVID-19 ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome and multiorgan dysfunction.
Key words: COVID-19; SARS-CoV-2;Pediatrics;Cardiac Injury

Introduction
The 2019 coronavirus pandemic (COVID-19) was caused by the SARS-CoV-2 virus, which led to a worldwide outbreak of sickness. Symptoms such as cough, fever, chills, and subsequent difficulty breathing and low oxygen levels are the acute manifestations of the condition. Ischemia, arrhythmias, venous thromboembolism, acute coronary syndrome, myocardial damage, and other cardiovascular problems may occur in adults due to this infection. (1-3).
In adults infected with SARS-CoV-2, the risk of morbidity and death is higher if they have preexisting cardiovascular disorders. However, the majority of SARS-CoV-2 infected children and teenagers either show no symptoms at all or have a mild case of the illness. Acute cardiac dysfunction, arrhythmias or conduction anomalies, and coronary artery dilatation may be caused by the uncommon but severe post inflammatory consequence of SARS-CoV-2 infection in children, known as multisystem inflammatory syndrome in children (MIS-C). (Figure 1) (4-7).